5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-7.34%
Both companies show declining revenue. Martin Whitman would check for industry-wide issues.
1.18%
Cost increase while STERV.HE reduces costs. John Neff would investigate competitive disadvantage.
-27.70%
Gross profit decline while STERV.HE shows 3.45% growth. Joel Greenblatt would examine competitive position.
-21.97%
Margin decline while STERV.HE shows 7.03% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.76%
Other expenses reduction while STERV.HE shows 19.12% growth. Joel Greenblatt would examine efficiency.
-10.76%
Operating expenses reduction while STERV.HE shows 8.45% growth. Joel Greenblatt would examine advantage.
-0.87%
Both companies reducing total costs. Martin Whitman would check industry trends.
-16.67%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-29.24%
D&A reduction while STERV.HE shows 23.13% growth. Joel Greenblatt would examine efficiency.
-42.25%
EBITDA decline while STERV.HE shows 13.90% growth. Joel Greenblatt would examine position.
-36.76%
EBITDA margin decline while STERV.HE shows 55.85% growth. Joel Greenblatt would examine position.
-44.39%
Operating income decline while STERV.HE shows 37.96% growth. Joel Greenblatt would examine position.
-39.98%
Operating margin decline while STERV.HE shows 42.73% growth. Joel Greenblatt would examine position.
-29.00%
Other expenses reduction while STERV.HE shows 38.10% growth. Joel Greenblatt would examine advantage.
-38.71%
Pre-tax income decline while STERV.HE shows 48.66% growth. Joel Greenblatt would examine position.
-33.86%
Pre-tax margin decline while STERV.HE shows 53.80% growth. Joel Greenblatt would examine position.
-80.41%
Tax expense reduction while STERV.HE shows 1.23% growth. Joel Greenblatt would examine advantage.
-35.91%
Net income decline while STERV.HE shows 57.53% growth. Joel Greenblatt would examine position.
-30.84%
Net margin decline while STERV.HE shows 62.97% growth. Joel Greenblatt would examine position.
-36.36%
EPS decline while STERV.HE shows 57.45% growth. Joel Greenblatt would examine position.
-36.36%
Diluted EPS decline while STERV.HE shows 57.45% growth. Joel Greenblatt would examine position.
-0.28%
Share count reduction while STERV.HE shows 0.00% change. Joel Greenblatt would examine strategy.
-0.43%
Diluted share reduction while STERV.HE shows 0.00% change. Joel Greenblatt would examine strategy.